Back to Trials
NCT07084363NARecruiting

Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

The University of Texas Health Science Center, Houston

Start Date

9/22/2025

Completion Date

4/1/2026

Summary

The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion criteria: * Patient age ≥ 18 years old; * General anesthesia with endotracheal intubation; * Neuromuscular block with rocuronium. Exclusion criteria: * Intubation before induction of anesthesia; * Critically ill patients admitted from the ICU; * Emergency cases; * Non-intubated patients; * Patients who will not be paralyzed through the surgery (spine). * Patients with an implanted electronic device (e.g. cardiac pacemaker) * Patients with allergies to adhesive * Patients with pre-existing neuromuscular disease (e.g. Myasthenia Gravis)

Interventions

DEVICE

Quantitative monitoring

OTHER

Qualitative monitoring

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Neuromuscular Block, Residual

Locations

The University of Texas Health Science Center at Houston

Houston, Texas 77030

United States